This protocol is judged by an institutional critique board, an unbiased group that evaluations any scientific trials involving people. If a research includes a Routine I drug, as soon as the board approves the protocol as ethical, the researchers must submit an application for an investigational new drug (IND) selection within the FDA.When undernea